Bangalore-based Strides Arcolab Ltd, which sold its injectable-medicine unit Agila Specialties for $1.65 billion to Mylan, has struck a deal to buy small drug maker Shasun Pharmaceuticals Ltd in an all stock merger. Based on the previous day’s closing share price, the deal is worth a little over $221 million.
The boards of both the companies have approved a scheme of amalgamation between the two companies, as per a stock market disclosure.
Help employers find you! Check out all the jobs and post your resume.
